Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 31, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Obtains New $10.6 Million Secured Debt Financing; Prepays Outstanding Convertible Notes

EpiCept Obtains New $10.6 Million Secured Debt Financing; Prepays Outstanding Convertible Notes TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...
May 19, 2011 17:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the 18th Annual Euro-Biotech Forum

EpiCept to Present at the 18th Annual Euro-Biotech Forum TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm:...
May 10, 2011 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Reports First Quarter 2011 Financial Results and Provides Business Update

EpiCept Corporation Reports First Quarter 2011 Financial Results and Provides Business Update Conference Call Begins at 9:00 A.M. Eastern Time Today TARRYTOWN, N.Y.--(BUSINESS...
May 09, 2011 18:05 ET | Source: Immune Pharmaceuticals Inc

EpiCept Files Protocol with FDA for Ceplene® Phase III Confirmatory Trial

EpiCept Files Protocol with FDA for Ceplene® Phase III Confirmatory Trial SPECIAL PROTOCOL ASSESSMENT WILL FACILITATE NDA SUBMISSION TARRYTOWN, N.Y.--(BUSINESS...
May 05, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report First Quarter 2011 Operating and Financial Results on May 10, 2011

EpiCept to Report First Quarter 2011 Operating and Financial Results on May 10, 2011 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq...
May 02, 2011 18:01 ET | Source: Immune Pharmaceuticals Inc

Notice of the Annual Meeting of Stockholders of EpiCept Corporation

Notice of the Annual Meeting of Stockholders of EpiCept Corporation TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: With this notice, stockholders of EpiCept...
April 28, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept's Board of Directors Appoints New Independent Member

EpiCept's Board of Directors Appoints New Independent Member TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm:...
April 08, 2011 17:00 ET | Source: Immune Pharmaceuticals Inc

EpiCept Receives Nasdaq Staff Determination Letter

EpiCept Receives Nasdaq Staff Determination Letter Company to Appeal for Additional Time to Regain Compliance TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory...
March 29, 2011 00:16 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Raise $4.6 Million in Registered Direct Offering

EpiCept to Raise $4.6 Million in Registered Direct Offering TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- EpiCept Corporation (Nasdaq and OMX Stockholm Exchange: EPCT)...
March 28, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference

EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...